l e t t e r s
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs that leads to profound disability and premature death. To identify new SSc susceptibility loci, we conducted the first genome-wide association study in a population of European ancestry including a total of 2,296 individuals with SSc and 5,171 controls. Analysis of 279,621 autosomal SNPs followed by replication testing in an independent case-control set of European ancestry (2,753 individuals with SSc (cases) and 4,569 controls) identified a new susceptibility locus for systemic sclerosis at CD247 (1q22-23, rs2056626, P = 2.09 × 10 −7 in the discovery samples, P = 3.39 × 10 −9 in the combined analysis). Additionally, we confirm and firmly establish the role of the MHC (P = 2.31 × 10 −18 ), IRF5 (P = 1.86 × 10 −13 ) and STAT4 (P = 3.37 × 10 −9 ) gene regions as SSc genetic risk factors.
SSc is a profoundly disabling autoimmune disease characterized by vascular damage, altered immune responses and abnormal fibrosis of skin and internal organs leading to premature death in affected individuals 1 . The etiology of SSc is complex and poorly understood, but as with most autoimmune conditions, it is widely accepted that environmental genetic factors contribute to disease risk. Data from familial, twin and ethnicity studies support the relevance of the genetic component in SSc etiology 2 . Previous studies aimed at dissecting the genetic factors underlying SSc genetic susceptibility have used the candidate gene association study approach 3 . In spite of several years of research, this strategy has yielded a very limited characterization of SSc genetic risk factors. Except for the major histocompatibility complex (MHC) genes, which are relevant genetic markers for SSc across populations, few other loci outside the human leukocyte antigen (HLA) region have demonstrated strong and reproducible associations with SSc Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus l e t t e r s susceptibility 3, 4 . Only very recently have large case-control association studies identified STAT4 and IRF5 as genetic factors contributing to SSc susceptibility [5] [6] [7] [8] . As for other complex genetic disorders, it is expected that several genetic markers contribute to SSc predisposition with modest effects and therefore large sample sizes are required to detect new disease-associated loci 9 .
Therefore, we aimed more comprehensively to identify new SSc susceptibility loci and thus conducted the first genome-wide association study (GWAS) of SSc, including a total of 2,296 SSc cases and 5,171 healthy controls from four case-control series of European ancestry (from United States, Spain, Germany and The Netherlands) (Supplementary Table 1 ). Genotyping of the SSc case sets and Spanish controls was performed using the Illumina Bead-Array platform with chips of different SNP densities (Supplementary Table 1 ). The genotypes of the US controls were obtained from the Cancer Genetic Markers of Susceptibility (CGEMS) studies and the Illumina iControlDB database; German and Dutch control groups were extracted from previous studies or public databases [10] [11] [12] [13] .
After rigorous genotyping quality-control filters, a total of 279,621 SNPs shared between the four case-control series were extracted for analysis (Supplementary Table 1 ).
The genomic inflation factor (λ) was estimated for the complete combined dataset and showed evidence of a modest inflation of test statistics (λ = 1.069). When the HLA region was excluded from the analysis, the inflation of test statistics somewhat decreased (λ = 1.066) (Supplementary Fig. 1 ). To adjust for potential population stratification, we applied a genomic control correction to the test statistics. The potential effect of population substructure was tested by deriving principal components on a population-specific basis. We observed that case and control individuals in each population were not significantly different on the basis of these principal components and were therefore well genetically matched. We also performed an inverse variance-based meta-analysis, adjusting the odds ratios for the first five country-specific principal components. This analysis showed little variation from genomic control-corrected P values ( Table 1) .
The Mantel-Haenszel test under an allelic model revealed several SNPs reaching P values at genome-wide significance after genomiccontrol correction (P ≤ 5 × 10 −7 ) (Fig. 1) . The strongest association signal was observed for a cluster of SNPs in an extended region at the 6p21 locus within the MHC region, whereas the rs6457617 SNP located in the HLA-DQB1 gene region gave the highest P value (P genomic control-corrected = 2.31 × 10 −18 ) ( Fig. 1 and Supplementary Table 2) . Outside the MHC region, five loci showed association at P < 10 −7 , namely the TNPO3-IRF5 region in 7q32, STAT4 in 2q32, CD247 in 1q22-23, CDH7 in 18q22 and EXOC2-IRF4 near 6p25. The trend observed for all these loci was consistent across the different study populations (Supplementary Table 3) . Furthermore, the TNPO3-IRF5 locus obtained genome wide significance in the single US cohort and was further corroborated in the European cohorts (Supplementary Table 3 ).
SNPs mapping to the region of TNPO3-IRF5 and STAT4 achieved the strongest association observed for non-HLA genes (rs10488631, P = 1.86 × 10 −13 , OR = 1.50, 95% CI 1.35-1.67; rs3821236, P = 3.37 × 10 −9 , OR = 1.30, 95% CI 1.18-1.44) ( Table 1 and Supplementary  Table 3 ). Therefore, these results confirm the previously reported role of the MHC region, STAT4 and IRF5 as genetic risk factors for SSc and identify three new candidate loci [3] [4] [5] [6] [7] [8] .
We next aimed to confirm the association of the CD247, CDH7 and EXOC2-IRF4 loci with SSc susceptibility using a large independent replication case-control set comprising 2,753 SSc cases and 4,569 controls of European ancestry (Supplementary Table 4) . The SNPs showing the strongest GWAS association on each region (rs2056626 for CD247, rs10515998 for CDH7 and rs4959270 for EXOC2-IRF4) were genotyped in the replication cohorts using TaqMan 5′ allelic discrimination assay technology. The association analysis by a MantelHaenszel test revealed a significant association of the rs2056626 genetic variant in the CD247 region (P = 3.07 × 10 −3 , OR = 0.89, 95% CI 0.83-0.96) ( Table 2 and Fig. 2) . The combined analysis of the GWAS and replication cohort for this SNP revealed a highly significant association (P = 3.39 × 10 −9 , OR = 0.86, 95% CI 0.81-0.90). The association of the SNPs in the CDH7 and EXOC2-IRF4 regions was not confirmed in this replication cohort ( Table 2 and Supplementary Fig. 2) . Considering that the frequency observed for the CDH7 rs10515998 genetic variant is quite low (around 5%), the population size of the replication cohort reached only 13% statistical power to detect an association at a significance level similar to that observed in the replication analysis (OR = 1.05). Therefore, the possible implication of the CDH7 locus in SSc genetic predisposition 
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HLA region -log 10 (P) l e t t e r s should be further investigated. In contrast, because of the high minor allele frequency (MAF) of the rs4959270 polymorphism in the EXOC2-IRF4 region, great heterogeneity of the association was observed in the replication cohorts (Supplementary Fig. 1 ). These findings are concordant with previous GWAS studies in which great population allelic heterogeneity has been reported for EXOC2-IRF4 genetic variants leading to false positive disease associations, as may have occurred in our screening phase 14 . Notably, the newly identified SSc susceptibility locus, CD247, encodes a protein that participates in the regulation of immune response and thus could have a role in SSc pathogenesis. CD247 encodes the T-cell receptor zeta (CD3ζ) subunit, a component of the T-cell receptor (TCR)-CD3 complex 15 . The CD3ζ chain plays an important role in the assembly of the TCR-CD3 complex and its transport to the cell surface and is crucial to receptor signaling function. It has been observed that the expression of the CD3ζ chain is altered in chronic autoimmune and inflammatory disorders and that its low expression results in impaired immune response [16] [17] [18] . Notably, CD247 has been associated with susceptibility to systemic lupus erythematosus, another systemic autoimmune disease 19, 20 . Moreover, genetic variants in the 3′ untranslated region of this gene have shown functional implications leading to a reduced expression of the CD3ζ chain that could be manifested in systemic autoimmunity 19 . Therefore, further studies aiming to dissect the exact role of this molecule in SSc will be of interest. This work represents the first large GWAS study conducted to date in SSc. Of note, the results obtained confirm and firmly establish the role of the HLA region, STAT4 and IRF5 in the genetic predisposition to SSc; these loci are also known to be risk factors for several other autoimmune conditions. In addition, a new susceptibility locus not previously considered as a susceptibility factor for SSc has been identified. All these findings support the strong autoimmune component underlying SSc pathogenesis and highlight the fact that the development of SSc seems to be determined by shared common genetic and pathogenic mechanisms with other autoimmune diseases and involves specific disease pathways that should be further characterized.
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